Skip to main content
VVT MED INC. logo

VVT MED INC. — Investor Relations & Filings

Ticker · VVTM ISIN · CA91841T1084 TSXV Manufacturing
Filings indexed 362 across all filing types
Latest filing 2022-03-22 Regulatory Filings
Country CA Canada
Listing TSXV VVTM

About VVT MED INC.

https://www.vvtmed.com/

VVT MED INC. develops, manufactures, and commercializes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of varicose veins and chronic venous disorders. The company's technology centers on the ScleroSafe Platform, a patented delivery system for Endovenous Chemical Ablation (ECA). ScleroSafe is designed to simplify procedures, shorten treatment times, and minimize patient recovery compared to traditional surgical and ablation methods. Products like ScleroSafe and V-Block, which treats severely dilated Great Saphenous Vein conditions, offer enhanced safety and efficacy. The platform holds regulatory clearances including FDA 510(k) and CE approval.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2022-03-22 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2022-03-22 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notice from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General Meeting (AGM) of DXI Capital Corp. It provides details about the meeting type, record dates, meeting date, location, and proxy material handling. The document does not contain financial statements, management discussion, or detailed report content. It is a notification about the AGM logistics rather than the AGM materials or report itself. Given the short length (1131 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related notices about the AGM.
2022-03-15 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-11-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2021-11-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-08-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.